About the Event
With more than 1.6 million new cancer cases in the United States in 2020, employers need to stay educated, raise awareness about the importance and value of early cancer detection and learn how to address gaps in care. In November 2023, Genentech and Employers Health brought together like-minded benefits professionals to work together to improve cancer care for all. Listen in as they discuss the latest in prevention and treatment, discuss health equity’s effect on cancer outcomes and share best practices and actionable takeaways.
In this session, we hear from Robert Baird, Jr., RN, MSA, president at the National Cancer Treatment Alliance. He covers:
- The importance of biomarker testing to ensure the right treatment at the right time.
- How Comprehensive Genomic Profiling (CGP) can not only improve patient outcomes but decrease absenteeism and presenteeism.
- The NCTA’s Employer Toolkit.
This presentation was previously recorded at the Employer-Focused Oncology Initiative: Improving Cancer Care for All on November 3, 2023.